
Arcella is an augmented computational life science platform based in the Netherlands that transforms biomedical data into valuable insights to redefine personalized medicine and drug discovery. It offers integrated data collection, innovative analytics, and intelligent insights through products such as a patient app for colorectal cancer, a scientific research engine for fast and accurate text and figure search, market and competitor intelligence tools, and an API providing access to structured raw biomedical data. The platform supports next-generation approaches in healthcare and research, with a business model based on subscription services. Arcella is co-funded by the European Union and has a strong team including founders with expertise in economics, bioinformatics, and medical science, supported by a scientific advisory board and experienced board of directors. The company emphasizes rapid extraction and analysis of biomedical literature, leveraging technologies like natural language processing and machine learning to deliver actionable insights for personalized medicine and drug discovery.

Arcella is an augmented computational life science platform based in the Netherlands that transforms biomedical data into valuable insights to redefine personalized medicine and drug discovery. It offers integrated data collection, innovative analytics, and intelligent insights through products such as a patient app for colorectal cancer, a scientific research engine for fast and accurate text and figure search, market and competitor intelligence tools, and an API providing access to structured raw biomedical data. The platform supports next-generation approaches in healthcare and research, with a business model based on subscription services. Arcella is co-funded by the European Union and has a strong team including founders with expertise in economics, bioinformatics, and medical science, supported by a scientific advisory board and experienced board of directors. The company emphasizes rapid extraction and analysis of biomedical literature, leveraging technologies like natural language processing and machine learning to deliver actionable insights for personalized medicine and drug discovery.